<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=510762&amp;fmt=gif">
Skip to content
RheoSenseJuly 12, 20131 min read

The Importance of Viscosity Measurements in Protein Therapeutics

South San Francisco Conference CenterHeadquartered in Silicon Valley, RheoSense is minutes from South San Francisco, heart of the blooming biotechnology industry in California.  Many of RheoSense’s existing and potential clients are situated in this hub of technology and innovation.  RheoSense hosted a seminar at the South San Francisco Conference Center on June 20, 2013. Entitled “The Importance of Viscosity Measurements in Protein Therapeutics: Challenges & Solutions,” the event featured three experts from East and West Coast: Professor Gareth H. McKinley (MIT), Dr. Jai Pathak (MedImmune), and Dr. Li Song (Oligasis).
 
RheoSense and Speakers. Left to right: Vitus Lau, Dr. Li Song (Oligasis), Dr. Jai Pathak (MedImmune), and Dr. Rajib Ahmed
 
RheoSense and Speakers. Left to right: Vitus Lau, Dr. Li Song (Oligasis), Dr. Jai Pathak (MedImmune), and Dr. Rajib Ahmed
 
 

Vitus Lau, Director, Global Marketing & International Sales, welcomed speakers and guests with a brief presentation on RheoSense’s marketing focus and global presence.  The Speakers proceeded to give their quality educational presentations.  Many attendants asked questions and received insightful answers. Substantive discussions ensued between speakers and attendants.  Later, Dr. Rajib Ahmed, Strategic Account Manager, delivered a detailed presentation on RheoSense technology and instruments.  His presentation sparked much interest, leaving people eager to view the demonstration scheduled for the afternoon.  After a very savory lunch, Dr. Ying-Chih Wang, Senior Manager, exhibited the easy-to-use m-VROC technology and tested samples submitted by an attendee. Marveling at the instrument and technology, participants convened around m-VROC and Dr. Wang.

Viscosity in Protein Therapeutics Seminar
 
Seminar participants gathering around Dr. Ying-Chih Wang during product demonstration
 
 

We are delighted with the seminar's results and look forward to developing additional seminars in the major biotech hubs of the USA.  Several Rheosense distribution partners around the globe have expressed interest in conducting seminars later this year.  We look forward to work with our partners and help them create successful events in all corners of the world.

RheoSense and Speakers. Left to right: Grace, Dr. Ying-Chih Wang, Dr. Rajib Ahmed, Vitus Lau, Dr. Seong-Gi Baek, Dr. Gareth H. McKinley (MIT), and Dr. Jai Pathak (MedImmune) RheoSense and Speakers.
Left to right: Grace, Dr. Ying-Chih Wang, Dr. Rajib Ahmed, Vitus Lau, Dr. Seong-Gi Baek, Dr. Gareth H. McKinley (MIT), and Dr. Jai Pathak (MedImmune)
avatar

RheoSense

RheoSense is a global high-tech company based in Silicon Valley. Our innovative m-VROC & microVISC instruments feature patented Viscometer/Rheometer-on-a-Chip (VROC) technology. Utilizing state-of-the-art MEMS and microfluidics breakthroughs that redefine the viscometry industry, our instruments offer the smallest sample volume per measurement coupled with exceptional ease-of-use and accuracy. We are the leader in biotechnology, pharmaceutical, and the emerging protein therapeutics industries. RheoSense instruments have been rigorously tested, approved, and adopted worldwide by Fortune Global 500 companies and leading research universities.

COMMENTS